Matterworks
Jack Geremia is the CEO of Matterworks and a founding partner of the company. Jack has over 25 years of experience in biotechnology and pharmaceuticals. Jack was the Vice-President of R&D at Kaleido Biosciences and the Founder & Head of Technology at Midori USA, Inc. Jack has a degree in Biochemistry from the University of California, Davis.
Jack Geremia received their Ph.D. in Chemistry from Princeton University and then went on to be a Postdoctoral Fellow in Control & Dynamical Systems at the Division of Engineering & Applied Science at Caltech. Jack received their Honors B.S. in Chemistry & Biochemistry from the University of Delaware.
This person is not in any offices
Matterworks
1 followers
Matterworks is enabling scalable metabolomics through AI and analytical chemistry to accelerate therapeutic research, development, and manufacturing.